Health Canada Approves Certolizumab Pegol & NICE Issues Guidance for Certolizumab Pegol

Michele B. Kaufman, PharmD, BCGP, is a freelance medical writer based in New York City and a pharmacist at New York Presbyterian Lower Manhattan Hospital.

References

1. UCB Canada Inc. News release: Health Canada approves Cimzia (certolizumab pegol) for moderate to severe psoriasis. 2019 Mar 25.
2. National Institute for Health and Care Excellence. Guidance: Certolizumab pegol for treating moderate to severe plaque psoriasis. 2019 Apr 17.